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Abstract Impaired lung development afflicts a range of
newborns cared for by paediatric surgeons. As a result the
speciality has led in the development of surgical models
that illustrate the biomechanical regulation of lung growth.
Using transgenic mutants, biologists have similarly dis-
covered much about the biochemical regulation of prenatal
lung growth. Airway smooth muscle (ASM) and its pre-
natal contractility airway peristalsis (AP) represent a novel
link between these areas: ASM progenitors produce an
essential biochemical factor for lung morphogenesis, whilst
calcium-driven biomechanical ASM activity appears to
regulate the same. In this invited paper, I take the oppor-
tunity both to review our recent findings on lung growth
and prenatal ASM, and also to discuss mechanisms by
which ASM contractility can regulate growth. Finally, I
will introduce some novel ideas for exploration: ASM
contractility could help to schedule parturition (pulmonary
parturition clock) and could even be a generic model for
smooth muscle regulation of morphogenesis in similar
organs.
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Why lung development matters to paediatric surgeons
Lung development is important to paediatric surgeons.
Lung hypoplasia and its lethal sequlae afflict a spectrum of
our patients ranging from those with congenital diaphrag-
matic hernia (CDH) or prenatal uropathies to massive
abdominal wall defects [1–4]. Similarly, congenital cyst-
adenomatoid lung malformations and bronchopulmonary
sequestrations present to paediatric surgeons as antenatally
diagnosed masses or postnatally with symptomatic chest
lesions [5, 6]. Moreover, several of our patients are born
prematurely with incomplete development that predisposes
to lung disease of prematurity [7]. Finally many of our
patients with CDH and tracheo-oesophageal fistula/
oesophageal atresia have chronic respiratory morbidity that
affects growth and may affect decisions for further sur-
geries (such as fundoplication) [8, 9] (Fig. 1).
Given this wide impact of lung development and dis-
ease on paediatric surgical practice, it is perhaps no sur-
prise that neonatal surgeons have been at the forefront of
investigation: the most notable contribution has been the
creation of in vivo fetal models of lung maldevelopment
that have allowed us to understand the regulation of
pulmonary growth and to design strategies to promote it
prenatally (e.g. surgically created models of CDH and
obstructive uropathies) [10, 11] (Fig. 2). Moreover, pae-
diatric surgeons have taken a leading role in development
of extracorporeal membrane oxygenation as a rescue
therapy for refractory respiratory failure and have col-
laborated in the evaluation and adoption of perinatology
approaches such as antenatal glucocorticoids, inhaled
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nitric oxide, permissive hypercapnoea and sildenafil for
surgical patients [12–17].
An overview of lung development reveals points
of clinical importance
Anatomically the mammalian lung develops as a diver-
ticulum from the primitive foregut [18]. Through iterated
epithelial branching (branching morphogenesis), the air-
ways take form [18, 19]. Early direct vascular supply
from the aorta to the lung normally dwindles: abnormal
persistence is observed in sequestrations [20, 21]. Pul-
monary vascular development was previously held to
follow airway morphogenesis. However recent studies
indicate that vascularisation may be an important pro-
moter of airway growth and terminal differentiation [22,
23]. Temporally, the pulmonary diverticulum emerges at
around 4 weeks of gestation; failure of the diverticulum to
separate normally is thought to explain tracheo-oesopha-
geal fistulae [18, 24]; most airway branching occurs be-
tween 6 and 16 weeks [25, 26]; vascular connectivity to
establish the respiratory surface for gas exchange emerges
around 22 weeks onward (hence the putative limit to
survival of preterm birth) [27]; human alveolarisation is in
progress by birth and commonly reported to continue
through early childhood [25]. Physiologically, the lung
undergoes dramatic changes between fetal and neonatal
life. Prenatally, the lung is fluid filled and respiratory gas
exchange is undertaken instead via the placenta (providing
the rationale for the EXIT procedure for, e.g. congenital
airway obstructions) [28, 29]. Primitive endodermal cells
differentiate into several lineages of which the most
studied are the types 1 and 2 pneumocyte and which may
also include pulmonary stem cells [30, 31]. Pulmonary
epithelium is responsible for lung liquid production (via
chloride-secretion): this results in prenatal lung having a
small positive intraluminal pressure relative to the tho-
racic cavity [32]. Abnormal persistence of this lung fluid
after birth is held responsible for transient tachypnoea of
Fig. 1 Problems of lung
development and function are
not confined to CDH: a Contrast
swallow (lateral view) after
delayed primary repair of
oesophageal atresia (OA)
without distal fistula. Such
children may face major
respiratory problems
(tracheomalacia and aspiration
+/– reflux) that can present as,
e.g. life-threatening episodes or
later with reactive airways
disease; b Giant gastroschisis
with major liver herniation:
such newborns face significant
respiratory difficulties requiring,
in this case, long-term
ventilation after eventual
abdominal closure. Both images
used with parental consent and
courtesy of the author
Fig. 2 Surgical models elucidate the biomechanical regulation of
lung growth: the gravid ovine uterus has been delivered at
laparotomy. Sonography is being used to determine placental and
fetal positions prior to hysterotomy. These methods of manipulating
the ovine fetus have allowed several models to be created (CDH,
obstructive uropathy, gastroschisis and myelomeningocele). Of
course, forms of lung hypoplasia generated this way may differ
importantly from both teratogenic/transgenic models and indeed
humans. Image courtesy of the author
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the newborn [33]. Surfactant production by type 2 pneu-
mocytes is a further adaptation that assists in lung infla-
tion at birth and resists airspace collapse. Surfactant
deficiency is associated with respiratory distress syndrome
in premature newborns and may occur in other disorders
such as CDH [34, 35]. Estimation of lung maturity has
been attempted by assaying surfactant-related metabolites
in amniotic fluid [36–38]. Whilst the epithelium has ab-
sorbed much scientific interest for conferring tissue spe-
cialisation (liquid production, surfactant manufacture), the
pulmonary mesenchyme is essential to lung development
[39]. Stripping embryonic lung buds of mesenchyme halts
their branching; replacing tracheal mesenchyme with that
from end-buds restarts epithelial branching at the trachea
[40]. Moreover, murine mutants lacking specific mesen-
chymal gene expression exhibit both lung lesions and
diaphragmatic defects with some phenotypic similarities
to human CDH [41–43]. These observations illustrate the
importance of pulmonary mesenchyme and also support
the concept that an early mesenchymal lesion in CDH can
generate both lung hypoplasia and diaphragmatic defect
[44–46] (Fig. 3). As we shall see, the latest evidence
suggests that pulmonary mesenchyme and its derivatives
have both biochemical and biomechanical roles in the
regulation of lung development.
Understanding of lung development derives
from a variety of sources
Our understanding of how the lung develops has been
aided by comparative biology, transgenic and teratogenic
mutants, surgically created models of in vivo physiology
and human ‘experiments of nature’. Comparative biology
has enabled us to appreciate that much of lung devel-
opment (epithelial branching morphogenesis, vasculo-
genesis and angiogenesis) is conserved through evolution
[47, 48]. This in turn has enabled the similarities with
comparable processes in other mammalian organs (pan-
creas, salivary gland and kidney) to be exploited [49,
50]. Transgenic mutant gene knockout animals have been
particularly helpful in establishing the biochemical reg-
ulation of airway development by demonstrating the
necessary roles of certain growth and transcription fac-
tors [51, 52]. In contrast, surgical models of modified
lung development have permitted the biomechanical
regulation of lung development to be elucidated [10, 11,
53]. Furthermore, human cases have provided vivid
illustrations of the biomechanical regulators of lung
growth (congenital laryngeal atresia, Potter’s syndrome)
[54, 55]. Despite the wealth of knowledge generated by
these separate approaches, a unifying model that brings
together biochemical and biomechanical regulation of
lung growth is still being sought [56–58]. We have been
addressing this by studying potential links between bio-
mechanical and biochemical stimuli; in so doing we and
others are appreciating new roles for pulmonary mesen-
chyme in lung organogenesis.
The biochemical regulation of lung development
A key biochemical interaction that underpins lung
development is that of fibroblast growth factor-10
(FGF10) and its cognate receptor FGFR2IIIb. Both ligand
and receptor have been conserved through evolution and
Fig. 3 Non-surgical models of abnormal lung growth are also
valuable: teratogenic and transgenic models illustrate that some
clinical problems of lung function may have their roots much earlier
in development than appreciated from surgical models alone. This
shows photomicrographs of whole lung primordia in organ culture.
Shown on the left of the figure is the longitudinal development of a
normal lung rudiment. For comparison the development of a nitrofen-
exposed lung rudiment is shown on the right at the same timepoints.
All specimens are at the same magnification (scale bar 400l m) and
the trachea lies superiorly in each case. Nitrofen-exposed lung
primordia are growth-impaired prior to the visceral hernia superven-
ing. Image courtesy of the author
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are homologous with the branchless and breathless genes
that are essential for airway branching in Drosophila [48].
In a parallel manner, both FGF10 and FGFR2IIIb have
been shown to be necessary for lung development in
transgenic knockout mice [59–62]. Functional loss of ei-
ther leads to lung agenesis in the offspring. In vitro lung
culture studies have shown that FGF10 induces epithelial
branching and can in fact largely substitute in this regard
for pulmonary mesenchyme: FGF10 stimulates branching
of epithelial only cultures in Matrigel [63]. Abnormalities
of FGFs and related heparan sulphate signalling have been
demonstrated in experimental lung hypoplasia [64–68].
Several other biochemical regulators of lung morphogen-
esis are arrayed around the FGF10–FGFR2IIIb interaction
(and extensively reviewed elsewhere) [51, 52]. However
for the purposes of this review, a focus on this central
pathway is sufficient. As we shall see, this archetypal
biochemical effector of lung growth may in fact also have
a role to play in the biomechanical regulation that we will
now survey.
The biomechanical regulation of lung development
Fetal breathing movements, lung liquid production and
maintenance of fetal thoracic and amniotic volumes are
necessary for normal lung development [55]. Ablation of
fetal breathing movements either by phrenic nerve abla-
tion or generation of amyogenic transgenic murine mu-
tants is associated with forms of lung hypoplasia [69, 70].
Excessive lung liquid loss induced by fetal tracheostomy
similarly impairs lung growth [71]. Compromise of tho-
racic volume by visceral herniation in CDH models or due
to external fetal compression from oligohydramnios in
prenatal uropathies are both associated with forms of lung
hypoplasia [11, 72]. Finally, and more difficult to explain,
massive abdominal wall defects with extensive liver her-
niation are also associated with clinically significant lung
impairment and often a narrowed thorax [4]. Speculating,
it may be that gross reduction in abdominal domain re-
sults in commensurate limitation of thoracic growth.
Others have suggested that liver herniation draws the
diaphragm down leading to major airways becoming
kinked across the pulmonary vessels with resulting bron-
chomalacia [73]. Finally, it is difficult to separate out the
deleterious effects of barotrauma resulting from the pro-
longed ventilation that such babies often require. Having
considered the substantial effects that biomechanical
stimuli can have on lung development, we can now turn
to the focus of our recent work on a biomechanical pul-
monary phenomenon that has been long described but
largely overlooked.
Airway smooth muscle: ‘appendix
of the lung’ or regulator of growth?
From the earliest stages of lung development and
throughout subsequent prenatal life the developing lung
is itself vigorously mechanically active [74–77]. Peri-
staltic waves of airway smooth muscle (ASM) rhythmi-
cally propagate throughout the airway tree with resulting
propulsion of all important lung liquid (Fig. 4). As a
result the growing end buds of the lung (where ASM
elaboration is at a minimum) experience phasic disten-
sion and relaxation [74, 75]. This curious activity has
been observed in airway explants from avian, rodent and
human species and they appear to increase in frequency
as gestation progresses [74–77]. Why the developing
lung should expend so much effort in the synthesis of
contractile apparatus and its mechanical activity has re-
mained a mystery. Certainly, rhythmic stretch-relaxation
modulates growth and gene expression in a range of cell
types including pulmonary epithelium and appears quite
distinct from the effects of static stretch [78, 79]. How-
ever, why this vibrant peristaltic contractility should
suddenly disappear at birth and how it relates to post-
natal ASM function and dysfunction are also unknown.
Given these uncertainties, we have explored prenatal
ASM activity, its regulation and its potential purposes.
Most fascinating has been emerging evidence that in
ASM peristalsis, we may have an important bridge be-
tween biomechanical and biochemical stimuli to lung
growth. Finally, the insights gained from our studies hold
the promise that strategies to treat prenatal lung hypo-
plasia and postnatal reactive airway disease can be
modified to achieve greater efficacy.
Prenatal ASM peristalsis appears coupled
to lung growth
We began with the seemingly simple task of determining
where and when in development ASM peristalsis emerges.
Our data showed that even embryonic rodent explants
equivalent to roughly 5 weeks of human gestation would
exhibit powerful peristaltic contractility in vitro [75].
Contrary to expectation, these waves did not arise simply
from the trachea and propagate distally. In fact it appears
that ASM contraction can arise throughout the proximal
airways at this stage but with a clear predilection for the
proximal right lung (‘pulmonary pacemaker‘‘) [75].
Moreover this area of the developing lung seems to
dominate and be autonomous of the remainder of the
lung: isolation of other areas of the lung from the influ-
ence of the right led to more frequent contractility in the
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isolated segment; in contrast, isolation of the right lung
did not alter peristaltic frequency therein [75]. To ascer-
tain what was driving this activity, we used calcium
imaging and c-kit immunoreactivity to show that ASM
peristalsis was underpinned by spontaneous propagating
calcium waves that arise in the apparent absence of Cajal-
type pacemaker cells [75, 80] (Fig. 5a). To explore the
purpose of such contractility we alternately stimulated or
inhibited either peristalsis or lung growth. In normal
embryonic lung we discovered that growth and peristalsis
were coupled: modulation of one was reliably accompa-
nied by parallel alteration in the other [75]. In particular,
we had an indication of a link between a typical bio-
chemical regulator of lung growth (FGF10) and a bio-
mechanical one (ASM peristalsis): FGF10-stimulated lung
growth was associated with significant increase in peri-
stalsis frequency [75]. Hence, these studies showed a
degree of coupling between ASM peristalsis and FGF10-
driven lung growth and supported the concept that one
may regulate the other. Furthermore, given that ASM
peristalsis depends on propagating calcium waves, these
data indicate that such calcium waves may in turn regu-
late lung growth [80].
Ca2+: biochemical mechanism for ASM regulation
of lung development?
In preliminary studies to explore, how calcium may regu-
late lung growth we have identified some interesting phe-
nomena. L-type calcium channel blockade with nifedipine
reduces intracellular calcium, halts airway peristalsis (AP)
(inducing a flaccid paresis) and stunts lung size but without
significantly diminishing branching [75, 81]. In contrast,
blocking sarcoplasmic calcium reuptake with cyclopiaz-
onic acid raises intracellular calcium leading to a tetanic
paresis (and halt of airway contractility) and is associated
with a remarkable and complete abolition of branching
morphogenesis [82, 83] (Fig. 5b). Moreover this latter ef-
fect is associated with loss of smooth muscle actin
expression (SMA: an early marker of ASM lineage) [83].
Removal of cyclopiazonic acid leads to resumption of
apparently normal branching and SMA expression [83].
Given that ASM progenitors specifically furnish the FGF10
required for airway branching [84], we therefore hypoth-
esise that cyclopiazonic acid may be acting on ASM pro-
genitors to halt both commitment (loss of SMA expression)
and also FGF10 production (loss of branching). Supporting
Fig. 4 Airway peristalsis—a
novel regulator of lung growth?
Left hand panels: fluid flux
within the epithelial lumen
(dark) of cultured lung can be
visualised due to the peristaltic
propulsion of cellular debris
(leading edge arrowed) seen
here on rapid sequence
photography of whole lung.
Right hand panels: airway
contraction (boxed) during a
wave of airway peristalsis. A
video of airway peristalsis from
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the idea that sarcoplasmic calcium regulates both FGF10-
driven branching morphogenesis and ASM elaboration,
one of the first described human genopathies relating to
loss of sarcoplasmic calcium reuptake is associated with
dysregulated proliferation an epithelium that, like the air-
way, is FGFR2IIIb-bearing and FGF10-responsive [85].
A biomechanical mechanism for ASM regulation
of lung development?
We have also argued that coupled elaboration of FGF10
and ASM could operate as a biological feedback mecha-
nism to maintain intraluminal pressures in the growing
lung (loss of such pressure is associated with lung hypo-
plasia) [46]. As the lung lumen increases in volume due to
FGF10 mediated growth, maintenance of intraluminal
pressure would require increased lung liquid production
and/or increased wall tension. The latter (and perhaps even
the former—vide infra) could be supplied by increased
ASM elaboration and activity: as more ASM progenitors
produce FGF10 and growth, more differentiated ASM
develops to influence airway wall tension and maintain
luminal pressure. Moreover, early work suggests that ASM
peristalsis is associated not only with propagating calcium
waves but potentially with chloride efflux from ASM. We
hypothesise that this chloride could be taken up at the
adjacent basolateral epithelial surface to drive epithelial
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Fig. 5 Ca2+ waves underpin
airway peristalsis and hence




Ca2+ waves with the initiation
site (marked by an asterisk) in
the trachea (top row) and right
lung rudiment (bottom row);
b blockade of sarcoplasmic
calcium reuptake with
cyclopiazonic acid (CPA) leads
to raised intracellular Ca2+
(y-axis) and rapid abolition of
Ca2+ oscillations over time (x-
axis). As described in the text,
this is associated with
replacement of peristalsis by
sustained airway contraction,
halting of branching and loss of
SMA expression (not shown);
c superimposed ASM Ca2+
transients measured from
normal and nitrofen lung (as
labelled) showing altered
morphology in lung hypoplasia
832 Pediatr Surg Int (2007) 23:827–836
123
chloride-secretion led production of lung liquid. Hence
ASM peristalsis may regulate growth-related intraluminal
pressures not only via its influence on wall tension but also
through modulation of all important lung liquid production.
What then are the implications for abnormal lung
development? Lung hypoplasia is associated with abnor-
malities of prenatal ASM-related signalling and postnatal
function in human CDH and in experimental CDH lung [8,
86, 87]. We have now shown that the coupling between
peristalsis and growth, the underpinning calcium waves
and the stereotypical maturation of peristaltic activity are
all abnormal in teratogen-induced lung hypoplasia [88, 89]
(Fig. 5c). Prenatal ASM may also play key roles in other
heterogenous forms of experimental lung hypoplasia:
myogenic knockout mice where intercostal musculature
+/– diaphragmatic muscularisation are ablated appear to
have normal ASM elaboration up to and beyond the point
at which fetal breathing supervenes [70]. In only those
mutants lacking both intercostal and diaphragmatic mus-
cularisation, SMA expression then appears to diminish in
late gestation [70]. Although the impact on SMA expres-
sion in other thoracic organs (e.g. oesophagus) was not
described, it could be that fetal breathing is important for
the maintenance of ASM. Assuming the degree of lung
hypoplasia manifest in amyogenic mutants is worse than
those lacking intercostals alone, the late loss of ASM
peristalsis (when it should be most active and widespread)
may contribute to this.
Therefore, contrary to the view that ASM is ‘the
appendix of the lung’ with no useful function [90–93], it
appears that ASM is critical to aspects of prenatal lung
growth: it provides FGF10 (from progenitors), mechanical
stretch-relaxation and even perhaps lung liquid production.
Encouraged by our discoveries, we began to explore the
role of smooth muscle contractility in the development of
other hollow organs using gut organ culture and calcium
fluorophores. Our idea has been eagerly taken over by
colleagues who continue to look at prenatal gut contrac-
tility using these techniques.
Future directions and potential clinical applications
Having considered the biological roles of prenatal ASM
(and some of the mechanisms by which it may perform
them), we can now consider potential clinical applications.
In translating prenatal ASM biology from bench to bedside,
technological development may have a significant part to
play. Improved imaging +/– remote telemetry could allow
us to visualise AP and/or measure resulting luminal pres-
sure changes in utero [94, 95]. Given the observed rela-
tionship between peristaltic frequency and gestation [76],
such measures might be used to provide a readily repeat-
able, non-biochemical estimate of lung maturity. This
would be of great benefit in selecting cases for prenatal
intervention or expeditious early delivery. Moreover, lung
development following, e.g. tracheal occlusion might be
monitored in real time by looking at peristalsis frequency.
Following evidence that cyclical tracheal occlusion may be
superior to static devices [96], there is also potential for
devices that allow balloon pump occlusion of the trachea to
optimise resulting lung development (‘preventilation‘‘/dy-
namicPLUG) [46]. Imaging prenatal ASM contractility
could even perhaps allow us to identify asthma-predispos-
tions prenatally and discover new drug targets to combat
ASM hypertrophy and airway remodelling in asthma (the
commonest chronic disease in the developed world) [97].
Finally, the increasing frequency of ASM peristalsis
through gestation and the unexplained switch from peri-
stalsis to tonic contractility around birth could be important
in the timing of parturition. Teleologically, it would be
advantageous for some aspect(s) of fetal lung development
to signal readiness for parturition. Could ASM peristalsis
play a role in scheduling the changes in uterine contrac-
tility that herald labour? If ASM peristalsis is part of a
pulmonary parturition clock, could we identify pregnancies
at risk of preterm labour from airway contractility patterns
long before uterine contractility supervenes [98]? More-
over, could such understanding lead us to appreciate that
some lung disease associated with prematurity is cause
rather than simply effect?
Closing remarks
We already know that ASM can transform lung morphol-
ogy postnatally. In asthma, transient ASM constriction
contributes to reversible lung hyperinflation; chronic ASM-
related airway remodelling then participates in irreversible
hyper-expansion supervening [99]. Lung hyperinflation
that follows tracheal occlusion [100, 101] could even be
seen as mimicking hyperinflation due to ASM-mediated
small airway occlusions in asthma. Promisingly, pharma-
cological suppression of ASM hyperreactivity may pre-
vent, halt or even reverse many of these changes in
postnatal lung morphology [93, 99]. Given such dramatic
pulmonary sequelae of postnatal ASM activity and the
effects of ASM-targeted therapy, it is rational to explore
the roles of ASM in prenatal lung morphogenesis (and the
potential of ASM-related therapy). Our clinical experience
reminds us of the toll that abnormalities of lung growth
(prematurity, hypoplasia, CCAM, etc.) take on our patients.
Therefore by understanding the role(s) of prenatal ASM,
paediatric surgeons can make a further contribution to
knowledge and therapy of the lung pathologies that we
encounter in daily practice.
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